Join
Live feed
·
PRReleasevia Quantisnow
Nanobiotix S.A. logo

NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3

ByQuantisnow·Wall Street's wire, on your screen.
NBTX· Nanobiotix S.A.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBTX (Nanobiotix S.A.) and more on Quantisnow.